PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 4395: Medicare Prescription Drug Affordability Act of 2005

Before you vote › Federal bills

H.R. 4395: Medicare Prescription Drug Affordability Act of 2005

109th Congress · introduced 2005-11-18 · Health · Latest: Referred to the Subcommittee on Health.

federal

Follow this bill, step by step

  1. Where it came from: introduced 2005-11-18 · official record
  2. Who proposed it: Rep. Conyers, John, Jr. [D-MI-14] · what a sponsor is
  3. What happened next: no floor votes in our records yet. Why?
  4. Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Medicare Prescription Drug Affordability Act of 2005

Plain summary

Medicare Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to revise part D (Voluntary Prescription Drug Benefit Program) as added by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to provide for: (1) no premium; (2) no deductible; (3) coinsurance at a rate of 10%; (4) a $1,500 annual limit on out-of-pocket spending on covered drugs; and (5) reduced cost-sharing for lower-income individuals. Revises the Medigap program and the membership and duties of the Medicare payment advisory commission. Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug and Cosmetic Act to: (1) repeal certain sections of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 relating to importation of prescription drugs from Canada; and (2) restore previous law, amended to direct the Secretary of Health and Human Services to allow qualifying individuals (in addition to pharmacists and wholesalers) to import covered products. Repeals the mandate that the Secretary require a foreign seller to specify the original source of the product and the amount of each product lot originally received. Amends requirements for the testing of imported covered products. Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging. Establishes a permanent bipartisan Quality Control and Cost Containment Blue Ribbon Task Force. Repeals the Comparative Cost Adjustment Program and prohibits the application of law in a manner that prevents a Medicare beneficiary from continuing to obtain benefits under a traditional fee-for-service Medicare program. Amends SSA title XVIII to repeal the Medicare Advantage Regional Plan Stabilization Fund. Repeals Health Savings Accounts. Provides for application of risk adjustment reflecting characteristics for the entire Medicare population. Directs the Secretary to make a specified phased-in adjustment of payment rates to Medicare+Choice payment organizations. Repeals the Medicare expenditure cap. Provides for continuous open enrollment in Medicare Advantage Plans.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Medicare Prescription Drug Affordability Act of 2005

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Conyers, John, Jr. [D-MI-14] · 5 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)
Securities
Financial investments that can be bought and sold, such as stocks and bonds.

Plain meanings written from linked sources. All words.

Sources

Record fed-us-cong109-hr4395 · catalog fed-us-congress-bills-cong109 · updated 2026-11-15 by psicol fed-bills-cong109